Discover 1,972 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,972
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Solid Tumor
Location: Miami FL, Houston TX, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05981703
Phase 1, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for
Melanoma, Cutaneous Malignant
Location: Miami FL, Tampa FL, Jacksonville FL, Chapel Hill NC,
Sponsor: Immatics US, Inc.
Sex: All
Age: 18+
Code: NCT06743126
Phase 3, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for
Relapsed or Refractory Multiple Myeloma (RRMM)
Location: Miami FL, Jacksonville FL, Atlanta GA, Charlotte NC,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06615479
Phase 3, Recruiting
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
for
Acute Myeloid Leukemia (AML)
Location: Miami FL, Cincinnati, OH, Houston TX, Canton OH,
Sponsor: Aptevo Therapeutics
Sex: All
Age: 18+
Code: NCT06634394
Phase 1, Recruiting
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma